Rita C Tostes Selected Research

CCX832

12/2018	Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways.
5/2017	Adipokine Chemerin Bridges Metabolic Dyslipidemia and Alveolar Bone Loss in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rita C Tostes Research Topics

Disease

54	Hypertension (High Blood Pressure) 01/2022 - 10/2003
23	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 01/2008
17	Obesity 01/2022 - 05/2008
17	Inflammation (Inflammations) 01/2021 - 10/2005
8	Erectile Dysfunction 09/2017 - 12/2008
7	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2010
7	Insulin Resistance 01/2019 - 11/2010
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 07/2014
6	Body Weight (Weight, Body) 12/2018 - 02/2006
6	Hyperglycemia 07/2018 - 02/2009
5	Vascular Remodeling 01/2021 - 06/2012
5	Stroke (Strokes) 08/2018 - 02/2009
4	Diabetes Mellitus 01/2021 - 10/2015
4	Dysbiosis 01/2021 - 05/2018
4	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2016
4	Atherosclerosis 01/2021 - 03/2009
4	Hypertrophy 01/2019 - 01/2014
3	Heart Failure 01/2021 - 04/2015
3	Fibrosis (Cirrhosis) 01/2021 - 07/2011
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2017
3	Vascular System Injuries 09/2015 - 01/2015
2	Infections 10/2022 - 01/2022
2	COVID-19 01/2022 - 07/2021
2	Sepsis (Septicemia) 12/2021 - 01/2019
2	Hypotension (Low Blood Pressure) 01/2020 - 01/2019
2	Dyslipidemias (Dyslipidemia) 01/2019 - 05/2017
2	Cardiomegaly (Heart Hypertrophy) 01/2019 - 01/2017
2	Vascular Diseases (Vascular Disease) 10/2018 - 01/2009
2	Weight Gain 05/2018 - 10/2015
2	Hyperaldosteronism (Conn Syndrome) 12/2016 - 07/2011
2	Albuminuria 01/2016 - 07/2011
2	Necrosis 08/2013 - 03/2009
1	Virus Diseases (Viral Diseases) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2005
13	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2005
11	SaltsIBA 05/2012 - 10/2003
9	CytokinesIBA 07/2021 - 01/2009
8	AldosteroneIBA 01/2021 - 10/2005
7	Vasoconstrictor AgentsIBA 10/2017 - 01/2008
7	Desoxycorticosterone Acetate (DOCA)FDA Link 05/2012 - 10/2003
6	Angiotensin IIIBA 01/2021 - 02/2008
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2010
5	Testosterone (Sustanon)FDA Link 01/2022 - 01/2012
5	AcetylglucosamineIBA 01/2022 - 02/2009
5	Ethanol (Ethyl Alcohol)IBA 12/2021 - 03/2008
5	AdipokinesIBA 01/2020 - 07/2014
5	MineralocorticoidsIBA 01/2019 - 04/2004
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2018 - 01/2012
5	Endothelin-1 (Endothelin 1)IBA 09/2011 - 10/2003
5	Desoxycorticosterone (Deoxycorticosterone)IBA 02/2009 - 10/2003
5	Endothelins (Endothelin)IBA 02/2009 - 10/2003
4	AntioxidantsIBA 03/2021 - 12/2015
4	InflammasomesIBA 01/2021 - 12/2016
4	Interleukin-10 (Interleukin 10)IBA 02/2019 - 08/2013
4	Insulin (Novolin)FDA Link 01/2019 - 01/2014
4	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2017 - 02/2006
4	Acetates (Acetic Acid Esters)FDA Link 02/2009 - 10/2003
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 07/2021 - 10/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2019 - 04/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 03/2009
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2019 - 01/2015
3	Estrogens (Estrogen)FDA Link 01/2019 - 03/2013
3	AndrogensIBA 09/2017 - 01/2012
3	EnzymesIBA 01/2017 - 11/2011
3	LipidsIBA 01/2016 - 06/2013
2	MelatoninIBA 10/2022 - 03/2021
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2021 - 03/2012
2	CalciumIBA 10/2021 - 02/2009
2	Pattern Recognition ReceptorsIBA 01/2021 - 01/2020
2	NLR ProteinsIBA 01/2020 - 01/2017
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 10/2017
2	Atorvastatin (Lipitor)FDA Link 03/2019 - 04/2015
2	Messenger RNA (mRNA)IBA 01/2019 - 05/2017
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019 - 10/2009
2	LipopolysaccharidesIBA 01/2019 - 01/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018 - 03/2010
2	CCX832IBA 12/2018 - 05/2017
2	Matrix Metalloproteinases (MMPs)IBA 11/2018 - 10/2017
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2018 - 10/2015
2	rho-Associated KinasesIBA 10/2016 - 01/2016
2	ProstaglandinsIBA 01/2016 - 08/2015
2	Leptin ReceptorsIBA 01/2015 - 05/2008
2	AngiotensinsIBA 01/2014 - 11/2004
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2014 - 01/2010
2	Clopidogrel (Plavix)FDA Link 01/2014 - 04/2010
2	ArginaseIBA 03/2011 - 12/2010
2	MagnesiumIBA 01/2011 - 12/2010
2	CationsIBA 01/2011 - 12/2010
2	Phosphotransferases (Kinase)IBA 03/2010 - 10/2005
2	Superoxides (Superoxide)IBA 03/2009 - 10/2003
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2021

Therapy/Procedure

5	Therapeutics 10/2021 - 01/2014
3	Ligation 12/2021 - 01/2019
2	Punctures 12/2021 - 01/2019
2	Denervation 07/2020 - 01/2020